TEP1 and myeloid sarcoma: However, our analysis of polymorphisms of the TEP1 rs1760904 and TERC rs12696304, rs35073794 genes between the group of individuals with MS aged ≥44 years and the control group did not reveal statistically significant differences (Table 7).